{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:28:17Z","timestamp":1770823697878,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T00:00:00Z","timestamp":1187049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Sentinel node (SN) status is the most important prognostic factor for overall survival in stage I or II melanoma. Yet SN-positive tumours with submicroscopic involvement of the SN (clusters of cells smaller than 0\u00b71 mm) have shown a distant recurrence rate of only 9 per cent at 5 years, as good as that in SN-negative patients. This study compared the outcome after completion lymph node dissection (CLND) in SN-positive tumours with elective total lymph node dissection (TLND) in patients with palpable nodes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 188 patients were identified; 124 had TLND and 64 had CLND. Median follow-up was 56 and 37 months respectively. There were no significant differences between the groups regarding tumour Breslow thickness, ulceration and site of the primary tumour. Survival rates were calculated from date of primary excision. All patients with primary melanomas on extremities or trunk were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>On univariable analysis, the site of the primary tumour (extremity versus trunk) (P &amp;lt; 0\u00b7001), Breslow thickness (P = 0\u00b7005) and ulceration (P &amp;lt; 0\u00b7001) were prognostic for overall survival. There was a non-significant 13 per cent difference in overall survival at 5 years between CLND and TLND (P = 0\u00b7115). Excluding 15 patients who had SN disease with submicrometastases reduced the difference to 6 per cent (P = 0\u00b7415).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study showed no significant survival benefit for SN-positive CLND compared with TLND, especially when patients with nodes containing submicrometastases were excluded.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.5814","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T14:19:03Z","timestamp":1187101143000},"page":"1293-1299","source":"Crossref","is-referenced-by-count":48,"title":["Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma"],"prefix":"10.1093","volume":"94","author":[{"given":"A C J","family":"van Akkooi","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Erasmus University Medical Centre \u2014 Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M G","family":"Bouwhuis","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Erasmus University Medical Centre \u2014 Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H W","family":"de Wilt","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Erasmus University Medical Centre \u2014 Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kliffen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus University Medical Centre \u2014 Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P I M","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Department of Statistics, Erasmus University Medical Centre \u2014 Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M M","family":"Eggermont","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Erasmus University Medical Centre \u2014 Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,8,14]]},"reference":[{"key":"2021070907375308000_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM197709222971202","article-title":"Inefficacy of immediate node dissection in stage 1 melanoma of the limbs","volume":"297","author":"Veronesi","year":"1977","journal-title":"N Engl J Med"},{"key":"2021070907375308000_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z","article-title":"A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results","volume":"41","author":"Sim","year":"1978","journal-title":"Cancer"},{"key":"2021070907375308000_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<276::AID-SSU3>3.0.CO;2-#","article-title":"Role of elective lymph node dissection in melanoma","volume":"14","author":"Hochwald","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"2021070907375308000_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme","volume":"351","author":"Cascinelli","year":"1998","journal-title":"Lancet"},{"key":"2021070907375308000_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"2021070907375308000_bib6","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021070907375308000_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejca.2005.10.023","article-title":"High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma","volume":"42","author":"van Akkooi","year":"2006","journal-title":"Eur J Cancer"},{"key":"2021070907375308000_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2003.07.170","article-title":"Clinical outcome of stage I\/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results","volume":"21","author":"Vuylsteke","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021070907375308000_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"2021070907375308000_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","article-title":"Clinical relevance of melanoma micrometastases (&lt; 0\u00b71 mm) in sentinel nodes: are these nodes to be considered negative?","volume":"17","author":"van Akkooi","year":"2006","journal-title":"Ann Oncol"},{"key":"2021070907375308000_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejso.2006.10.032","article-title":"Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma","volume":"33","author":"van Akkooi","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"2021070907375308000_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10434-000-0461-7","article-title":"Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up","volume":"7","author":"Statius Muller","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"2021070907375308000_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/path.1365","article-title":"The development of optimal pathological assessment of sentinel lymph nodes for melanoma","volume":"200","author":"Cook","year":"2003","journal-title":"J Pathol"},{"key":"2021070907375308000_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(05)67482-X","article-title":"Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb\/III melanoma (EORTC 18 952): randomised controlled trial","volume":"366","author":"Eggermont","year":"2005","journal-title":"Lancet"},{"key":"2021070907375308000_bib15","first-page":"38S","article-title":"The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer","volume":"8","author":"Eggermont","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"2021070907375308000_bib16","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1200\/JCO.2006.06.3198","article-title":"Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival","volume":"24","author":"Cascinelli","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021070907375308000_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.sla.0000086543.45557.cb","article-title":"Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases","volume":"238","author":"Morton","year":"2003","journal-title":"Ann Surg"},{"key":"2021070907375308000_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","article-title":"Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1\u00b70 to 4\u00b70 mm). Intergroup Melanoma Surgical Trial","volume":"7","author":"Balch","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"2021070907375308000_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10434-999-0442-4","article-title":"Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma","volume":"6","author":"Essner","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"2021070907375308000_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1245\/ASO.2004.01.026","article-title":"Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma","volume":"11","author":"Doubrovsky","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"2021070907375308000_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2003.07.003","article-title":"Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease","volume":"40","author":"Kretschmer","year":"2004","journal-title":"Eur J Cancer"},{"key":"2021070907375308000_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"2021070907375308000_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1470-2045(05)70518-0","article-title":"Time for comprehensive reporting of MSLT-I","volume":"7","author":"Thomas","year":"2006","journal-title":"Lancet Oncol"},{"key":"2021070907375308000_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/bjs.5255","article-title":"Caution with sentinel node biopsy in cutaneous melanoma","volume":"93","author":"Thomas","year":"2006","journal-title":"Br J Surg"},{"key":"2021070907375308000_bib25","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1200\/jco.2006.24.18_suppl.8004","article-title":"Microscopic tumor burden in sentinel lymph nodes (SLNs) best predicts nonsentinel lymph node (NSLN) involvement in patients with melanoma","volume":"24","author":"Andtbacka","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021070907375308000_bib26","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2668::AID-CNCR11>3.0.CO;2-R","article-title":"International Union Against Cancer. Classification of isolated tumor cells and micrometastasis","volume":"86","author":"Hermanek","year":"1999","journal-title":"Cancer"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.5814","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/94\/10\/1293\/36686212\/bjs5814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/94\/10\/1293\/36686212\/bjs5814.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T18:39:54Z","timestamp":1625855994000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/94\/10\/1293\/6156188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,14]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,8,14]]},"published-print":{"date-parts":[[2007,9,14]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.5814","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,10]]},"published":{"date-parts":[[2007,8,14]]}}}